Similarly, it is reported in different cancers with agents that activate cAMP that they can activate PAK4, such as thyroid-stimulating hormones in papillary thyroid cancer [97], C-X-C motif chemokine 12 in prostate cancer [119] and alpha-MSH in B16 melanoma cells [96]. Here, PAK4 is linked to prostate carcinoma.